AAAAAA
Results:
1-15
|
Results: 15
Authors:
Mahalati, K
Belitsky, P
West, K
Kiberd, B
Fraser, A
Sketris, I
Macdonald, AS
McAlister, V
Lawen, J
Citation: K. Mahalati et al., Approaching the therapeutic window for cyclosporine in kidney transplantation: A prospective study, J AM S NEPH, 12(4), 2001, pp. 828-833
Authors:
Belitsky, P
Gupta, R
Citation: P. Belitsky et R. Gupta, Fine-needle aspiration biopsy - New application for an old technique, TRANSPLANT, 71(6), 2001, pp. 709-710
Authors:
Hatch, DA
Koyle, MA
Baskin, LS
Zaontz, MR
Burns, MW
Tarry, WF
Barry, JM
Belitsky, P
Taylor, RJ
Citation: Da. Hatch et al., Kidney transplantation in children with urinary diversion or bladder augmentation, J UROL, 165(6), 2001, pp. 2265-2268
Authors:
Barama, A
Oza, U
Panek, R
Belitsky, P
MacDonald, AS
Lawen, J
McAlister, V
Kiberd, B
Citation: A. Barama et al., Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants, CLIN TRANSP, 14(3), 2000, pp. 212-217
Authors:
Belitsky, P
Dunn, S
Johnston, A
Levy, G
Citation: P. Belitsky et al., Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients, CLIN PHARMA, 39(2), 2000, pp. 117-125
Authors:
Mahalati, K
Belitsky, P
West, K
Kiberd, B
MacDonald, A
McAlister, V
Lawen, J
Citation: K. Mahalati et al., A 3-hour postdose cyclosporine level during the first week after kidney transplantation predicts acute rejection and cyclosporine nephrotoxicity moreaccurately than trough levels, TRANSPLAN P, 32(4), 2000, pp. 786-787
Authors:
Belitsky, P
Citation: P. Belitsky, Neoral use in the renal transplant recipient, TRANSPLAN P, 32(3A), 2000, pp. 10S-19S
Authors:
Belitsky, P
Levy, GA
Johnston, A
Citation: P. Belitsky et al., Neoral absorption profiling: An evolution in effectiveness, TRANSPLAN P, 32(3A), 2000, pp. 45S-52S
Authors:
Dominguez, J
Clase, CM
Mahalati, K
MacDonald, AS
McAlister, VC
Belitsky, P
Kiberd, B
Lawen, JG
Citation: J. Dominguez et al., Is routine ureteric stenting needed in kidney transplantation? A randomized trial, TRANSPLANT, 70(4), 2000, pp. 597-601
Authors:
Mahalati, K
Lawen, J
Kiberd, B
Belitsky, P
Citation: K. Mahalati et al., Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period?, J UROL, 163(1), 2000, pp. 37-41
Authors:
Belitsky, P
Mahalati, K
West, K
Sketris, I
Citation: P. Belitsky et al., Influence of drug formulation on utilization and outcomes: Neoral and monitoring by sparse sample area under the curve, TRANSPLAN P, 31(3), 1999, pp. 1667-1668
Authors:
Kahan, BD
Levy, G
Benet, L
Johnston, A
Barr, B
Helderman, H
Frei, U
Belitsky, P
Lodge, P
Citation: Bd. Kahan et al., Discussion of recommendations concerning the introduction of generic formulations of cyclosporine, TRANSPLAN P, 31(3), 1999, pp. 1675-1684
Authors:
Mahalati, K
Belitsky, P
Sketris, I
West, K
Panek, R
Citation: K. Mahalati et al., Neoral monitoring by simplified sparse sampling area under the concentration-time curve - Its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation, TRANSPLANT, 68(1), 1999, pp. 55-62
Authors:
West, KA
Anderson, DR
McAlister, VC
Hewlett, TJC
Belitsky, P
Smith, JW
Kelton, JG
Citation: Ka. West et al., Alloimmune thrombocytopenia after organ transplantation, N ENG J MED, 341(20), 1999, pp. 1504-1507
Authors:
Kiberd, B
Panek, R
Clase, CM
MacDonald, AS
McAlister, V
Belitsky, P
Lawen, J
Citation: B. Kiberd et al., The morbidity of prolonged wound drainage after kidney transplantation, J UROL, 161(5), 1999, pp. 1467-1469
Risultati:
1-15
|